| Identification | |||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Glycine | ||||||||||||||||||||||||||||||||||||||||||
| Accession Number | DB00145 (NUTR00028) | ||||||||||||||||||||||||||||||||||||||||||
| Type | small molecule | ||||||||||||||||||||||||||||||||||||||||||
| Groups | approved, nutraceutical | ||||||||||||||||||||||||||||||||||||||||||
| Description | A non-essential amino acid. It is found primarily in gelatin and silk fibroin and used therapeutically as a nutrient. It is also a fast inhibitory neurotransmitter. [PubChem] |
||||||||||||||||||||||||||||||||||||||||||
| Structure |
Download: MOL | SDF | SMILES | InChI Display: 2D Structure | 3D Structure |
||||||||||||||||||||||||||||||||||||||||||
| Synonyms |
|
||||||||||||||||||||||||||||||||||||||||||
| Salts | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Brand names |
|
||||||||||||||||||||||||||||||||||||||||||
| Brand mixtures | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Categories |
|
||||||||||||||||||||||||||||||||||||||||||
| CAS number | 56-40-6 | ||||||||||||||||||||||||||||||||||||||||||
| Weight |
Average: 75.0666 Monoisotopic: 75.032028409 |
||||||||||||||||||||||||||||||||||||||||||
| Chemical Formula | C2H5NO2 | ||||||||||||||||||||||||||||||||||||||||||
| InChI Key | InChIKey=DHMQDGOQFOQNFH-UHFFFAOYSA-N | ||||||||||||||||||||||||||||||||||||||||||
| InChI |
InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)
Plain Text
|
||||||||||||||||||||||||||||||||||||||||||
| IUPAC Name |
2-aminoacetic acid
|
||||||||||||||||||||||||||||||||||||||||||
| SMILES |
NCC(O)=O
Plain Text
|
||||||||||||||||||||||||||||||||||||||||||
| Mass Spec | show (6.91 KB) | ||||||||||||||||||||||||||||||||||||||||||
| Taxonomy | |||||||||||||||||||||||||||||||||||||||||||
| Kingdom | Organic | ||||||||||||||||||||||||||||||||||||||||||
| Classes |
|
||||||||||||||||||||||||||||||||||||||||||
| Substructures |
|
||||||||||||||||||||||||||||||||||||||||||
| Pharmacology | |||||||||||||||||||||||||||||||||||||||||||
| Indication | Supplemental glycine may have antispastic activity. Very early findings suggest it may also have antipsychotic activity as well as antioxidant and anti-inflammatory activities. | ||||||||||||||||||||||||||||||||||||||||||
| Pharmacodynamics | Helps trigger the release of oxygen to the energy requiring cell-making process; Important in the manufacturing of hormones responsible for a strong immune system. | ||||||||||||||||||||||||||||||||||||||||||
| Mechanism of action | In the CNS, there exist strychnine-sensitive glycine binding sites as well as strychnine-insensitive glycine binding sites. The strychnine-insensitive glycine-binding site is located on the NMDA receptor complex. The strychnine-sensitive glycine receptor complex is comprised of a chloride channel and is a member of the ligand-gated ion channel superfamily. The putative antispastic activity of supplemental glycine could be mediated by glycine's binding to strychnine-sensitive binding sites in the spinal cord. This would result in increased chloride conductance and consequent enhancement of inhibitory neurotransmission. The ability of glycine to potentiate NMDA receptor-mediated neurotransmission raised the possibility of its use in the management of neuroleptic-resistant negative symptoms in schizophrenia. Animal studies indicate that supplemental glycine protects against endotoxin-induced lethality, hypoxia-reperfusion injury after liver transplantation, and D-galactosamine-mediated liver injury. Neutrophils are thought to participate in these pathologic processes via invasion of tissue and releasing such reactive oxygen species as superoxide. In vitro studies have shown that neutrophils contain a glycine-gated chloride channel that can attenuate increases in intracellular calcium and diminsh neutrophil oxidant production. This research is ealy-stage, but suggests that supplementary glycine may turn out to be useful in processes where neutrophil infiltration contributes to toxicity, such as ARDS. |
||||||||||||||||||||||||||||||||||||||||||
| Absorption | Absorbed from the small intestine via an active transport mechanism. | ||||||||||||||||||||||||||||||||||||||||||
| Volume of distribution | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Protein binding | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Metabolism | Hepatic | ||||||||||||||||||||||||||||||||||||||||||
| Route of elimination | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Half life | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Clearance | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Toxicity | ORL-RAT LD50 7930 mg/kg, SCU-RAT LD50 5200 mg/kg, IVN-RAT LD50 2600 mg/kg, ORL-MUS LD50 4920 mg/kg; Doses of 1 gram daily are very well tolerated. Mild gastrointestinal symptoms are infrequently noted. In one study doses of 90 grams daily were also well tole. | ||||||||||||||||||||||||||||||||||||||||||
| Affected organisms |
|
||||||||||||||||||||||||||||||||||||||||||
| Pathways | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Pharmacoeconomics | |||||||||||||||||||||||||||||||||||||||||||
| Manufacturers |
|
||||||||||||||||||||||||||||||||||||||||||
| Packagers | |||||||||||||||||||||||||||||||||||||||||||
| Dosage forms |
|
||||||||||||||||||||||||||||||||||||||||||
| Prices |
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational
purposes only.
|
||||||||||||||||||||||||||||||||||||||||||
| Patents | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Properties | |||||||||||||||||||||||||||||||||||||||||||
| State | solid | ||||||||||||||||||||||||||||||||||||||||||
| Experimental Properties |
|
||||||||||||||||||||||||||||||||||||||||||
| Predicted Properties |
|
||||||||||||||||||||||||||||||||||||||||||
| References | |||||||||||||||||||||||||||||||||||||||||||
| Synthesis Reference | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| General Reference | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| External Links |
|
||||||||||||||||||||||||||||||||||||||||||
| ATC Codes |
|
||||||||||||||||||||||||||||||||||||||||||
| AHFS Codes |
|
||||||||||||||||||||||||||||||||||||||||||
| PDB Entries | |||||||||||||||||||||||||||||||||||||||||||
| FDA label | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| MSDS | show (72.3 KB) | ||||||||||||||||||||||||||||||||||||||||||
| Interactions | |||||||||||||||||||||||||||||||||||||||||||
| Drug Interactions | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Food Interactions | Not Available | ||||||||||||||||||||||||||||||||||||||||||
| Targets |
|---|
|
1. 2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial Pharmacological action: unknownOrganism class: human UniProt ID: O75600 ![]() Gene: GCAT ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
2. 5-aminolevulinate synthase, nonspecific, mitochondrial Pharmacological action: unknownOrganism class: human UniProt ID: P13196 ![]() Gene: ALAS1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
3. 5-aminolevulinate synthase, erythroid-specific, mitochondrial Pharmacological action: unknownSuccinyl-CoA + glycine = 5-aminolevulinate + CoA + CO(2) Organism class: humanUniProt ID: P22557 ![]() Gene: ALAS2 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
4. Glycine cleavage system H protein, mitochondrial Pharmacological action: unknownThe glycine cleavage system catalyzes the degradation of glycine. The H protein shuttles the methylamine group of glycine from the P protein to the T protein Organism class: humanUniProt ID: P23434 ![]() Gene: GCSH ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
ATP + glycine + tRNA(Gly) = AMP + diphosphate + glycyl-tRNA(Gly) Organism class: humanUniProt ID: P41250 ![]() Gene: GARS ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
6. Glutamate [NMDA] receptor subunit epsilon-1 Pharmacological action: unknownActions: antagonist NMDA receptor subtype of glutamate-gated ion channels possesses high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine Organism class: humanUniProt ID: Q12879 ![]() Gene: GRIN2A ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
7. Bile acid CoA:amino acid N-acyltransferase Pharmacological action: unknownInvolved in bile acid metabolism. In liver hepatocytes catalyzes the second step in the conjugation of C24 bile acids (choloneates) to glycine and taurine before excretion into bile canaliculi. The major components of bile are cholic acid and chenodeoxycholic acid. In a first step the bile acids are converted to an acyl-CoA thioester, either in peroxisomes (primary bile acids deriving from the cholesterol pathway), or cytoplasmic at the endoplasmic reticulum (secondary bile acids). May catalyze the conjugation of primary or secondary bile acids, or both. The conjugation increases the detergent properties of bile acids in the intestine, which facilitates lipid and fat-soluble vitamin absorption. In turn, bile acids are deconjugated by bacteria in the intestine and are recycled back to the liver for reconjugation (secondary bile acids). May also act as an acyl-CoA thioesterase that regulates intracellular levels of free fatty acids. In vitro, catalyzes the hydrolysis of long- and very long-chain saturated acyl-CoAs to the free fatty acid and coenzyme A (CoASH), and conjugates glycine to these acyl-CoAs Organism class: humanUniProt ID: Q14032 ![]() Gene: BAAT ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
8. N-arachidonyl glycine receptor Pharmacological action: unknownReceptor for N-arachidonyl glycine. The activity of this receptor is mediated by G proteins which inhibit adenylyl cyclase. May contribute to regulation of the immune system Organism class: humanUniProt ID: Q14330 ![]() Gene: GPR18 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
Organism class: human UniProt ID: P48637 ![]() Gene: GSS ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
10. Glutamate [NMDA] receptor subunit epsilon-3 Pharmacological action: unknownNMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine Organism class: humanUniProt ID: Q14957 ![]() Gene: GRIN2C ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
11. Serine hydroxymethyltransferase 2 Pharmacological action: unknownOrganism class: human UniProt ID: Q53ET4 ![]() Protein Sequence: FASTA Gene Sequence: FASTA References:
12. SHMT2 protein Pharmacological action: unknownOrganism class: human UniProt ID: Q5BJF5 ![]() Gene: SHMT2 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 13. Hypothetical protein DKFZp686P09201 Pharmacological action: unknownOrganism class: human UniProt ID: Q5HYG8 ![]() Gene: DKFZp686P09201 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
Pharmacological action: unknown
Mitochondrial acyltransferase which transfers the acyl group to the N-terminus of glycine. Can conjugate a multitude of substrates to form a variety of N-acylglycines Organism class: humanUniProt ID: Q6IB77 ![]() Gene: GLYAT ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
15. Proton-coupled amino acid transporter 1 Pharmacological action: unknownNeutral amino acid/proton symporter. Has a pH-dependent electrogenic transport activity for small amino acids such as glycine, alanine and proline. Besides small apolar L-amino acids, it also recognize their D-enantiomers and selected amino acid derivatives such as gamma-aminobutyric acid Organism class: humanUniProt ID: Q7Z2H8 ![]() Gene: SLC36A1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
16. SHMT2 protein Pharmacological action: unknownOrganism class: human UniProt ID: Q8N1A5 ![]() Gene: SHMT2 Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
17. Glycine N-acyltransferase-like protein 2 Pharmacological action: unknownMitochondrial acyltransferase which transfers the acyl group to the N-terminus of glycine. Can conjugate a multitude of substrates to form a variety of N-acylglycines Organism class: humanUniProt ID: Q8WU03 ![]() Gene: GLYATL2 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 18. Glycine N-acyltransferase-like protein 1 Pharmacological action: unknownMitochondrial acyltransferase which transfers the acyl group to the N-terminus of glycine. Can conjugate a multitude of substrates to form a variety of N-acylglycines Organism class: humanUniProt ID: Q969I3 ![]() Gene: GLYATL1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 19. Alanine--glyoxylate aminotransferase 2, mitochondrial Pharmacological action: unknownOrganism class: human UniProt ID: Q9BYV1 ![]() Gene: AGXT2 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
20. Vesicular inhibitory amino acid transporter Pharmacological action: unknownInvolved in the uptake of GABA and glycine into the synaptic vesicles Organism class: humanUniProt ID: Q9H598 ![]() Gene: SLC32A1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
21. Peroxisomal sarcosine oxidase Pharmacological action: unknownMetabolizes sarcosine, L-pipecolic acid and L-proline Organism class: humanUniProt ID: Q9P0Z9 ![]() Gene: PIPOX ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References: 22. Sodium- and chloride-dependent glycine transporter 2 Pharmacological action: unknownTerminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals. May be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses Organism class: humanUniProt ID: Q9Y345 ![]() Gene: SLC6A5 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
23. Glutamate [NMDA] receptor subunit 3B Pharmacological action: unknownNMDA receptor subtype of glutamate-gated ion channels with reduced single-channel conductance, low calcium permeability and low voltage-dependent sensitivity to magnesium. Mediated by glycine Organism class: humanUniProt ID: O60391 ![]() Gene: GRIN3B ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
24. Glycine dehydrogenase [decarboxylating], mitochondrial Pharmacological action: unknownThe glycine cleavage system catalyzes the degradation of glycine. The P protein binds the alpha-amino group of glycine through its pyridoxal phosphate cofactor; CO(2) is released and the remaining methylamine moiety is then transferred to the lipoamide cofactor of the H protein Organism class: humanUniProt ID: P23378 ![]() Gene: GLDC ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
25. Sodium- and chloride-dependent glycine transporter 1 Pharmacological action: unknownTerminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals. May play a role in regulation of glycine levels in NMDA receptor-mediated neurotransmission Organism class: humanUniProt ID: P48067 ![]() Gene: SLC6A9 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
26. Glycine receptor subunit alpha-1 Pharmacological action: unknownThe glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing) Organism class: humanUniProt ID: P23415 ![]() Gene: GLRA1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
27. Serine--pyruvate aminotransferase Pharmacological action: unknownOrganism class: human UniProt ID: P21549 ![]() Gene: AGXT ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
28. Glycine receptor subunit beta Pharmacological action: unknownThe glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing) Organism class: humanUniProt ID: P48167 ![]() Gene: GLRB ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
29. Serine hydroxymethyltransferase, cytosolic Pharmacological action: unknownInterconversion of serine and glycine Organism class: humanUniProt ID: P34896 ![]() Gene: SHMT1 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
30. Glycine receptor subunit alpha-3 Pharmacological action: unknownThe glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing) Organism class: humanUniProt ID: O75311 ![]() Gene: GLRA3 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
31. Glycine receptor subunit alpha-2 Pharmacological action: unknownThe glycine receptor is a neurotransmitter-gated ion channel. Binding of glycine to its receptor increases the chloride conductance and thus produces hyperpolarization (inhibition of neuronal firing) Organism class: humanUniProt ID: P23416 ![]() Gene: GLRA2 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
32. Glycine N-methyltransferase Pharmacological action: unknownCatalyzes the methylation of glycine by using S- adenosylmethionine (AdoMet) to form N-methylglycine (sarcosine) with the concomitant production of S-adenosylhomocysteine (AdoHcy). Possible crucial role in the regulation of tissue concentration of AdoMet and of metabolism of methionine Organism class: humanUniProt ID: Q14749 ![]() Gene: GNMT ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
33. Serine hydroxymethyltransferase, mitochondrial Pharmacological action: unknownInterconversion of serine and glycine Organism class: humanUniProt ID: P34897 ![]() Gene: SHMT2 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
34. Glycine amidinotransferase, mitochondrial Pharmacological action: unknownOrganism class: human UniProt ID: P50440 ![]() Gene: GATM ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
|
| Transporters |
|---|
|
1. Monocarboxylate transporter 10 Actions: substrate, inhibitorSodium-independent transporter that mediates the update of aromatic acid. Can function as a net efflux pathway for aromatic amino acids in the basosolateral epithelial cells (By similarity) UniProt ID: Q8TF71![]() Gene: SLC16A10 ![]() Protein Sequence: FASTA Gene Sequence: FASTA SNPs: SNPJam Report ![]() References:
|
| Comments |
|---|